Ergomed PLC (LSE:ERGO) - Share price - Overview

Stock Report

Ergomed PLC ERGO

Last Price
GBX186.00

Day Change
0.00|0.00%

As of 15/02/2019
16:26:21 GMT | GBX
Minimum 15 Minutes Delay.

Last Close186.00p
Day Range183.00 - 186.00
Mkt Cap85.59Mil
52-Wk Range145.00 - 248.00
Yield %-
ISINGB00BN7ZCY67
Volume64,749
P/E-52.56
P/S0.02
P/CF31.00

Share Price

Total Returns 15/02/2019

 Chg (%)  
More ...
Ergomed PLC6.29 
FTSE 100 TR GBP5.30
 
Financials
201520162017
More ...
Income Statement
Turnover30.1839.2347.62
Operating Profit2.380.81-0.63
Net Profit1.55-0.07-4.50
Reported EPS5.20-0.20-11.00
Balance Sheet
Current Assets13.5019.6222.97
Non Current Assets11.1934.5638.94
Total Assets24.6954.1961.91
Current Liabilities7.238.5913.86
Total Liabilities7.7619.7927.07
Total Equity16.9434.4034.84
Cash Flow
Operating Cash Flow0.85-1.430.38
Net Change in Cash-0.600.45-1.21
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
24/12/2018Transfer outDr. Miroslav Reljanovic0.00176,4700.00
01/05/2018PurchaseDr. Jan Petracek187.2550,40994,391.00
16/04/2018SaleDr. Miroslav Reljanovic190.004,000,0007,600,000.00

Company Profile

Ergomed PLC is engaged in providing services to the pharmaceutical industry and develops new drugs. The company operates in two business divisions namely Clinical Research Services and Drug Safety and Medical Information Services.

Sector

Biotechnology

Index

FTSE AIM All-Share

Next Event 28/03/2019

Final Results
Ratios
Comp
More ...
PER (E)0.00
Div Yld (E)0.00
PEG (E)0.00
ROCE-9.25
Op Mrgn-0.01
EPS Grwth0.00
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
Directors
More ...
Non-Executive DirectorMr. Peter Lutz George
Executive Director, ChairmanDr. Miroslav Reljanovic
Executive Director, Chief Operating OfficerDr. Jan Petracek
Non-Executive DirectorMr. Christopher Collins
Executive Director, Chief Executive Officer, PrimeVigilanceMr. Neil Robert Clark
Executive Director, Chief Executive OfficerStephen Anthony Stamp
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2019 Morningstar. All rights reserved.